![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 18, 2019 5:43:43 AM
Yes...the Elephant in the room needs to be identified in order to know where it came from...was it on the plains???? OR was it from the forest??? All DD points to this possibly being a forest Elephant. There's just too many coincidences between the latest Instadose letter to shareholders and GNCP updates to shareholders. Among so many other similarities!!
Then we have Quebec-Canada, as you've mentioned. I can understand the reason for entering Quebec, since it's a region with the least issued licenses, BUT not when your competition is comng from J/V partner Instadose Pharma. Although, is it competition or another colaboration???
Ultimately, GNCP needs a global, controlling, executive staff to manage symentry of all these transactions in Canada,the US, Colombia, and South Africa / Europe. So far, I'm only reading a focus of South Africa and Europe from Ms. Allen & Mr. Cox, so there is most certainly a big part of this puzzle YET to be revealed!!
Can't wait, can't wait, can't wait!!!!
FEATURED North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM